OCX - OncoCyte Corp - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

OCX is currently covered by 3 analysts with an average price target of $21.38. This is a potential upside of $18.22 (576.58%) from yesterday's end of day stock price of $3.16.

OncoCyte Corp's activity chart (see below) currently has 51 price targets and 45 ratings on display. The stock rating distribution of OCX is 83.33% BUY and 16.67% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 42.41% with an average time for these price targets to be met of 63.55 days.

Highest price target for OCX is $8, Lowest price target is $4, average price target is $5.42.

Most recent stock forecast was given by THOMAS FLATEN from LAKE STREET on 21-May-2025. First documented stock forecast 24-Mar-2016.

Currently out of the existing stock ratings of OCX, 5 are a BUY (83.33%), 1 are a HOLD (16.67%).

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

Since 28-Mar-2025

$8

$4.84 (153.16%)

$5

7 months 20 days ago
(21-May-2025)

1/6 (16.67%)

$4.93 (160.59%)

204

Buy

Since 11-Nov-2021

$4.25

$1.09 (34.49%)

$4.25

7 months 28 days ago
(13-May-2025)

2/11 (18.18%)

$1.48 (53.43%)

58

Hold

Since 26-Mar-2025

$4

$0.84 (26.58%)

$25

9 months 15 days ago
(26-Mar-2025)

1/2 (50%)

$0.82 (25.79%)

16

Buy

Since 24-Mar-2016

$5

$1.84 (58.23%)

$5

1 years 8 months 26 days ago
(15-Apr-2024)

0/4 (0%)

$2.47 (97.63%)

Hold

Since 15-Aug-2023

$3

$-0.16 (-5.06%)

$3.5

2 years 1 months 28 days ago
(13-Nov-2023)

2/5 (40%)

$0.24 (8.70%)

2

Show more analysts

Please expand the browser size to see the chart

What is OCX (OncoCyte Corp) average time for price targets to be met?

On average it took 63.55 days on average for the stock forecasts to be realized with a an average price target met ratio 42.41

Which analyst has the current highest performing score on OCX (OncoCyte Corp) with a proven track record?

PAUL KNIGHT

Which analyst has the most public recommendations on OCX (OncoCyte Corp)?

Paul Knight works at KEYBANK and has 9 price targets and 6 ratings on OCX

Which analyst is the currently most bullish on OCX (OncoCyte Corp)?

Mark Massaro with highest potential upside - $156.84

Which analyst is the currently most reserved on OCX (OncoCyte Corp)?

David Westenberg with lowest potential downside - -$0.16

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?